-

Arrival SA Shareholder Alert: Robbins LLP Reminds Investors that Arrival SA (ARVL, ARVLW) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons who purchased or otherwise acquired common shares of Arrival SA (NASDAQ: ARVL, ARVLW) between November 18, 2020 and November 19, 2021, for violations of the Securities Exchange Act of 1934. Arrival manufactures and distributes commercial electric vehicles (EVs), including vans, cars, and buses.

If you suffered a loss due to Arrival SA's misconduct, click here.

Arrival SA (ARVL, ARVLW) Misled Investors Regarding its Business Prospects

According to the complaint, on March 24, 2021, Arrival combined with CIIG Merger Corp., a special purpose acquisition corporation, and began trading under the symbols ARVL and ARVLW on March 25, 2021. During the class period, defendants purportedly failed to disclose that: (i) the Company would record a substantially greater net loss and adjusted EBITDA loss in the third quarter 2021 compared to third quarter 2020; (ii) would experience far greater capital and operational expense to operate and deploy its microfactories and EV vehicles than it had disclosed; and (iii) would not achieve profitability or provide meaningful revenue in the time periods disclosed. Further, defendants failed to disclose that the Company would not achieve its disclosed production and sales volume or its production rollout deadlines.

The truth came out in a series of disclosures beginning on November 8, 2021. On that date, Arrival announced its financial results for the third quarter 2021, including a loss of €26 million (compared to a loss of €22 million during the same quarter a year earlier), and adjusted EBITDA loss for the quarter of €40 million (compared to a loss of €18 million in the third quarter of 2020). The Company also pulled its 2022 revenue goals and scaled back its long-term projections, pushing its production and sales timeline into later time periods. On this news, Arrival shares plummeted 24%, to close at $13.46 on November 10, 2021.

Then, on November 17, 2021, Arrival announced a $200 million offering of green convertible senior notes due 2026, intended to finance the development of EVs. On the same day, Arrival announced the commencement of an underwritten public offering of 25 million ordinary shares intended to raise around $330 million. On this news, Arrival shares dropped approximately 8%, to close at $9.91 per share on November 18, 2021, harming investors.

If you purchased shares of Arrival SA (ARVL, ARVLW) between November 18, 2020 and November 19, 2021, you have until February 22, 2022, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Arrival SA settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Nektar Therapeutics Class Action Reminder – Robbins LLP Encourages NKTR Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nektar Therapeutics (NASDAQ: NKTR) securities between February 26, 2025 and December 15, 2025. Nektar is a biopharmaceutical company focused on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders. The Company’s lead product candidate is rezpegaldesleukin, a novel, first-in-class regulat...

Robbins LLP Encourages SMCI Stockholders to Contact the Firm for Information About the Class Action Against Super Micro Computer, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Super Micro Computer, Inc. (NASDAQ: SMCI) securities between April 30, 2024 and March 19, 2026. Super Micro is a technology company that designs, develops, and manufactures high-performance server and storage systems, primarily for artificial intelligence (“AI”), data center, and cloud solutions customers.For more information, submit a form, em...

Robbins LLP Urges COTY Stockholders to Contact the Firm for Information About the Class Action Against Coty Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Coty Inc. (NYSE: COTY) common stock between November 5, 2025 and February 4, 2026. Coty together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products worldwide. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? November 5,...
Back to Newsroom